Valeant Pharmaceuticals Announces Continuance

CNW Group

LAVAL, Quebec , Aug. 9, 2013 /CNW/ - Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced that, effective August 9, 2013 , it has continued from the federal jurisdiction of Canada to the Province of British Columbia (the "Continuance") pursuant to a resolution passed by shareholders of the Company at the annual meeting held May 21 , 2013. The Continuance results in the Company becoming subject to all of the provisions of the British Columbia Business Corporations Act.

About Valeant Pharmaceuticals International, Inc.
Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, eye health, neurology and branded generics. More information about Valeant Pharmaceuticals International, Inc. can be found at www.valeant.com.

(Logo: http://photos.prnewswire.com/prnh/20101025/LA87217LOGO)

Contact Information:

Laurie W. Little
949-461-6002
laurie.little@valeant.com

SOURCE: Valeant Pharmaceuticals International, Inc.

Contact:

http://www.valeant.com

http://photos.prnewswire.com/prnh/20101025/LA87217LOGO

Rates

View Comments (0)